Institutional investors purchased a net $334.7 thousand shares of JNP during the quarter ended March 2015 and now own 27.24% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RICE, HALL, JAMES & ASSOCIATES L... Bought 37.2 Thousand shares of Juniper Pharmaceuticals I...